---
title: "Pathology Managed Service for Midlands & East 2 Network"
ocid: "ocds-h6vhtk-06c338"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06c338"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06c338.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06c338.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST"
published: "2026-07-03"
---

# Pathology Managed Service for Midlands & East 2 Network

Buyer: NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-06c338

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06c338)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06c338.json)

## Summary

The Nottingham University Hospitals NHS Trust has issued a contract award for the "Pathology Managed Service for Midlands & East 2 Network" under the NHS Supply Chain Framework. This procurement process falls under the services industry, specifically focusing on pathology services as classified by CPV code 85111800. The award was made without a prior call for competition, in accordance with the Public Contracts Regulations 2015, following a further competition under Lot 1 of the applicable framework. The award was confirmed on 4th June 2026, with Roche Diagnostics Ltd selected as the successful supplier for a contract initially valued at approximately £25,000,000, with the potential for the total contract value to reach between £25,000,000 and £155,300,000. The contract is active and includes a ten-year term with the option to extend by an additional two years.

This award presents significant opportunities for businesses within the pathology and healthcare services sector. Companies specialising in laboratory diagnostics, point of care testing, and managed services could benefit from subcontracting or partnership arrangements, especially in delivering Phase 2 services, which encompass immunology, blood transfusion, POCT, and various specialities including biochemistry, cellular pathology, and microbiology. The project encompasses a wide geographic scope, covering a network of NHS Trusts within the Midlands and East region, including key locations such as Derby, Leicester, Lincolnshire, Nottinghamshire, and North Lincolnshire, thus making it suitable for organisations with robust delivery capabilities and a focus on healthcare innovation.

## Notice

The Midlands and East 2 Network (the "ME2 Network") is a network-wide pathology collaboration in the Midlands and East 2 region, comprising the Contracting Authorities listed in this notice. The ME2 Network carried out a further competition for a pathology managed service under the NHS Supply Chain Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service Framework in accordance with the Public Contracts Regulations 2015. This contract award notice covers the contract for a pathology managed service awarded by the contracting authority in section I.1 of this notice.

### Lot Information

Lot 1

The Midlands East 2 Pathology Network is made of the following NHS Trusts: University Hospitals of Derby and Burton NHS Foundation Trust; Chesterfield Royal Hospital NHS Foundation Trust; Kettering General Hospital NHS Foundation Trust; Northampton General Hospital NHS Trust; University Hospitals of Leicester NHS Trust; Nottingham University Hospitals NHS Trust; Sherwood Forest Hospitals NHS Foundation Trust; United Lincolnshire Hospitals NHS Trust; and Northern Lincolnshire and Goole NHS Foundation Trust ("ME2 Network"). The ME2 Network carried out a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) to select a pathology managed service provider (the "Successful Supplier"). Nottingham University Hospitals NHS Trust has entered into its own contract with the Successful Supplier. This contract award notice is being published by Nottingham University Hospitals NHS Trust. The other NHS Trusts listed as part of the ME2 Network have also entered into separate contracts with the Successful Supplier although note that Northern Lincolnshire and Goole NHS Foundation Trust will enter into its contract for and on behalf of itself and United Lincolnshire Hospitals NHS Trust as the "Path Links" arrangement and this also includes pathology provision at Grimsby, Scunthorpe, Lincoln, Boston and Grantham hospitals and "Derbyshire Pathology" is hosted by University Hospitals of Derby and Burton NHS Foundation Trust, which includes Derby, Burton and Chesterfield Pathology services. The contract includes Phase 1 services: general managed services, biochemistry (including some elements of immunology and serology) and haematology services (including coagulation), pre and post analytical equipment with associated IT and middleware; and Phase 2 services: immunology, blood transfusion, POCT, specialist biochemistry, specialist haematology, cellular pathology (histopathology and mortuary), microbiology (molecular microbiology, bacteriology, serology (including virology)). In accordance with the terms of the contract, the Successful Supplier is responsible for the provision of Phase 1 services in accordance with the implementation plans set out in the contract. The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years. The Successful Supplier is required to work in collaboration with the ME2 Network to fully develop each of the NHS Trusts' requirements for phase 2 sub-disciplines, test the market and award the winning supplier (a sub-contractor) to provide the relevant Phase 2 service discipline, to ensure value for money and quality of delivery. The Successful Supplier will be responsible for fully managing its sub-contractors under the terms of the contract. The contract sets out the process and governance arrangements for initiating and delivering phase 2 services. The contract value of the Phase 1 services is approximately PS25,000,000. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS25,000,000 and PS155,300,000. Additional information: The value of the contract referred to in section II.I.7 refers to the contract value of the Phase 1 services which is approximately PS25,000,000. It is anticipated that the contract value of both Phase 1 and Phase 2 services shall be somewhere between PS25,000,000 and PS155,300,000

Options: The initial ten (10) year term will begin from the ME2 Network Actual Services Commencement Date (the date that the first of the ME2 Network contracts actually commences the delivery of all Phase 1 Services). The term of the contract may be extended for up to 2 years.

### Procurement Information

The contract was awarded following a further competition under Lot 1 of the NHS Supply Chain Framework Agreement for Laboratory Diagnostics, Point of Care Testing and Pathology Managed Services (Framework reference number 2023 S/00 028831) in accordance with the Public Contracts Regulations 2015 ("PCR"). There was therefore no prior publication of a notice and this contract award notice is being published for transparency as there is no obligation to publish a contract award notice following a further competition under a Framework Agreement under the PCR.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/062700-2026 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Jul 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 3 Jun 2026 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £25,000,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST |
| Locality | NOTTINGHAM |
| Post town | Nottingham |
| Postcode | NG5 1PB |
| Country | England |
| ITL 1 | TLF East Midlands (England) |
| ITL 2 | TLF1 Derbyshire and Nottinghamshire |
| ITL 3 | TLF14 Nottingham |
| Local authority | Nottingham |
| Electoral ward | Sherwood |
| Westminster constituency | Nottingham East |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ROCHE DIAGNOSTICS |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85111800 - Pathology services

## Release History

- 3 Jul 2026 at 10:37 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/062700-2026

## Notice URLs

- https://www.nuh.nhs.uk/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06c338. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06c338.json.